Literature DB >> 2091619

Virus-induced autoimmunity.

A Schattner1, B Rager-Zisman.   

Abstract

Viral infections in humans commonly result in the transient appearance of a variety of autoantibodies and, in some patients, the development of autoimmune tissue injury and disease. The capacity to cause or exacerbate an autoimmune process is common to many viruses, affecting mainly organs injured by the replicating virus, as demonstrated by several animal models. Viral "footprints" can often be found in patients with autoimmune diseases and include high titers of specific antiviral antibodies, identification of viral (retroviral) sequences, and the presence of alpha-interferons in the serum. Several mechanisms that are not mutually exclusive can account for the pathogenesis of virus-induced autoimmunity. Viruses may modify or release sequestered cellular proteins or affect the host's immune system by direct polyclonal activation of B cells, effects on immunoregulatory cells, and release of lymphokines. The appearance of antiviral antibodies may also be deleterious to the host through molecular mimicry, the generation of anti-idiotypic antibodies, or the formation of immune complexes. No single microorganism or mechanism can explain the extremely varied phenomena of autoimmunity, but growing evidence suggests that certain viral infections may lead to clinically manifest autoimmunity in individuals having genetic and possibly other predisposing factors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2091619     DOI: 10.1093/clinids/12.2.204

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  27 in total

1.  Presentation of autoantibody to proliferating cell nuclear antigen in patients with chronic hepatitis B and C virus infection.

Authors:  B S Tzang; T Y Chen; T C Hsu; Y C Liu; G J Tsay
Journal:  Ann Rheum Dis       Date:  1999-10       Impact factor: 19.103

2.  Infection of C3HeB/FeJ mice with the docile strain of lymphocytic choriomeningitis virus induces autoantibodies specific for erythrocyte Band 3.

Authors:  G Mazza; M E el Idrissi; J P Coutelier; A Corato; C J Elson; C J Pfau; M J Day
Journal:  Immunology       Date:  1997-06       Impact factor: 7.397

3.  High frequencies of human T-lymphotropic virus type I (HTLV-I) infection and presence of HTLV-II proviral DNA in blood donors with anti-thyroid antibodies.

Authors:  H Mine; H Kawai; K Yokoi; M Akaike; S Saito
Journal:  J Mol Med (Berl)       Date:  1996-08       Impact factor: 4.599

4.  Evidence of HTLV-I in thyroid tissue in an HTLV-I carrier with Hashimoto's thyroiditis.

Authors:  H Kawai; T Mitsui; K Yokoi; M Akaike; K Hirose; K Hizawa; S Saito
Journal:  J Mol Med (Berl)       Date:  1996-05       Impact factor: 4.599

5.  New insights into the pathogenesis of interstitial pulmonary fibrosis.

Authors:  S A Jimenez
Journal:  Thorax       Date:  1994-03       Impact factor: 9.139

6.  Divergent evolution may link human immunodeficiency virus GP41 to human CD4.

Authors:  A Facchiano; F Facchiano; J van Renswoude
Journal:  J Mol Evol       Date:  1993-05       Impact factor: 2.395

7.  Two short autoepitopes on the nuclear dot antigen are similar to epitopes encoded by the Epstein-Barr virus.

Authors:  K Xie; M Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

8.  Lack of connectivity between the induced and autoimmune repertoires of lpr/lpr mice.

Authors:  D L Very; D J Panka; D Weissman; L Wysocki; T Manser; A Marshak-Rothstein
Journal:  Immunology       Date:  1993-12       Impact factor: 7.397

Review 9.  HIV-mediated B-lymphocyte activation and lymphomagenesis.

Authors:  J G Monroe; L E Silberstein
Journal:  J Clin Immunol       Date:  1995-03       Impact factor: 8.317

Review 10.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.